Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids
- PMID: 8652189
- DOI: 10.1165/ajrcmb.14.6.8652189
Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids
Abstract
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease of unknown etiology in which the alveoli and terminal bronchioles of the lung fill with large amounts of surfactant-rich lipoproteinaceous materials. Its major pathologic manifestations are a small number of normal tubular myelin structures and an unusual abundance of multilamellated structures. Since surfactant protein A (SP-A) plays an important role in surfactant phospholipid homeostasis, we investigated the structural features of SP-A oligomers (alveolar proteinosis protein, APP) accumulating in the alveoli of individuals with PAP, and examined the abilities of APP to interact with lipids. Analysis of APP by Bio Gel A15m column chromatography revealed that it was composed of two protein peaks, one of which (APP-I) eluted at the position near that of blue dextran whereas the other (APP-II) eluted far behind blue dextran but ahead of thyroglobulin. These populations of APP showed almost identical amino acid compositions. Electron microscopic observations of APP molecules using the rotary shadow technique revealed that APP-II was observed as hexameric particles, presumably consisting mainly of octadecamers whose diameter was approximately 30 nm. The population seen for APP-II was similar to that seen for SP-A from healthy individuals. In contrast, APP-I was observed as multimerized larger aggregates whose diameter appeared to be about 70 to 90 nm. Both APP-I and APP-II retained the abilities to bind dipalmitoylphosphatidylcholine (DPPC). They also induced phospholipid vesicle aggregation in a concentration-dependent manner. The maximal turbidity for light scattering induced by APP-I and APP-II was almost equivalent when analyzed as a function of molar concentration. In vitro reconstitution experiments with porcine surfactant protein B (SP-B) and phospholipids revealed that the multilamellated membranes in structures formed from APP-I consisted of several layers of doubled unit membranes. APP-I failed to form tubular myelin structures. In contrast, APP-II formed well-formed lattice structures seen in tubular myelin. From these data we conclude that there exists an abnormal multimerized form of SP-A oligomer in the alveoli of patients with PAP, and that this unusual subpopulation of SP-A oligomer exhibits abnormal function on phospholipid membrane organization.
Similar articles
-
Human surfactant protein A with two distinct oligomeric structures which exhibit different capacities to interact with alveolar type II cells.Biochem J. 1996 Aug 1;317 ( Pt 3)(Pt 3):939-44. doi: 10.1042/bj3170939. Biochem J. 1996. PMID: 8760386 Free PMC article.
-
Immunoglobulin G is associated with surfactant protein A aggregate isolated from patients with pulmonary alveolar proteinosis.Am J Respir Crit Care Med. 1997 May;155(5):1785-8. doi: 10.1164/ajrccm.155.5.9154892. Am J Respir Crit Care Med. 1997. PMID: 9154892
-
Dissolution and reassembly of tubular myelin-like multilamellated structures from the lungs of patients with pulmonary alveolar proteinosis.Lab Invest. 1986 Aug;55(2):194-208. Lab Invest. 1986. PMID: 3755483
-
[Biochemical and clinical aspects of pulmonary surfactant proteins].Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30 Suppl:5-14. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1306239 Review. Japanese.
-
Role of surfactant protein A (SP-A)/lipid interactions for SP-A functions in the lung.Pediatr Pathol Mol Med. 2001 Jul-Aug;20(4):249-68. Pediatr Pathol Mol Med. 2001. PMID: 11486733 Review.
Cited by
-
Pulmonary collectins selectively permeabilize model bacterial membranes containing rough lipopolysaccharide.Biochemistry. 2006 Feb 28;45(8):2679-85. doi: 10.1021/bi0522652. Biochemistry. 2006. PMID: 16489761 Free PMC article.
-
Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2--impact on function.Crit Rev Eukaryot Gene Expr. 2009;19(2):125-37. doi: 10.1615/critreveukargeneexpr.v19.i2.30. Crit Rev Eukaryot Gene Expr. 2009. PMID: 19392648 Free PMC article. Review.
-
Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia.Infect Immun. 1999 Sep;67(9):4563-9. doi: 10.1128/IAI.67.9.4563-4569.1999. Infect Immun. 1999. PMID: 10456901 Free PMC article.
-
Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A.Infect Immun. 1999 Sep;67(9):4693-9. doi: 10.1128/IAI.67.9.4693-4699.1999. Infect Immun. 1999. PMID: 10456918 Free PMC article.
-
Assessment of surfactant protein A (SP-A) dependent agglutination.BMC Pulm Med. 2010 Nov 22;10:59. doi: 10.1186/1471-2466-10-59. BMC Pulm Med. 2010. PMID: 21092225 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials